Y. Fljjii, H. Tanaka, H. Toyooka
Oct 1, 1997
Citations
0
Influential Citations
26
Citations
Quality indicators
Journal
Acta Anaesthesiologica Scandinavica
Abstract
Background: Prophylactic use of granisetron, a selective Shydroxytryptamine type 3 receptor antagonist, reduces the incidence of nausea and vomiting after breast surgery. This study was undertaken to determine the minimum effective dose of granisetron in the reduction of postoperative nausea and vomiting (PONV) in patients undergoing general anaesthesia for breast surgery.